Novel Topical Gene Therapy for Devastating Rare Skin Diseases with Suma Krishnan Krystal Biotech

Published: Aug. 15, 2018, 9:48 p.m.

Suma M. Krishnan, Founder and COO, Krystal Biotech discusses their approach to treating rare genetic skin diseases that lack any truly effective treatments.  Krystal is developing the first ever topically applied gene therapy for the rare disease epidermolysis, a genetic condition characterized by extremely fragile skin that leads to devastating physical developments.  Krystal is looking to apply their novel gene therapy to treat a wide range of skin conditions for those of all ages.

#RareDisease #EpidermolysisBullosa #Ichthyosis #GeneTherapy #Dermatology #FightEB #IchthyosisAwareness

Krystal Biotech